# 177Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives

## TL;DR

This paper reviews how combining Lu-177 with magnetic nanoparticles can improve cancer treatment and imaging by delivering targeted radiation while minimizing harm to healthy cells.

## Contribution

The paper provides a comprehensive review of the synthesis, characterization, and biological applications of Lu-177-labeled magnetic nano-formulations.

## Key findings

- Lu-177-labeled magnetic nano-formulations offer dual benefits of targeted radiation therapy and MRI contrast enhancement.
- Surface functionalization and bioconjugation strategies are critical for improving the efficacy and specificity of these nano-formulations.
- Challenges such as scalability and regulatory hurdles remain barriers to clinical translation.

## Abstract

The advent of nanotechnology has revolutionized the field of medicine, particularly in the development of targeted therapeutic strategies. Among these, radiolabeled nanomaterials have emerged as promising tools for both diagnostic and therapeutic applications, offering precise delivery of radiation to diseased tissues while minimizing damage to healthy ones. Notably, Lutetium-177 (177Lu) has gained significant attention due to its favorable emission properties and availability that render it suitable for imaging and therapeutic purposes. When integrated with magnetic nano-formulations, 177Lu-labeled systems combine the benefits of targeted radiation therapy (TRT) with the unique properties of magnetic nanoparticles (MNPs), such as magnetic resonance imaging (MRI) contrast enhancement and magnetically guided drug delivery to address challenges in diagnosis and treatment of diseases, such as cancer. By examining the latest advancements in their design, particularly surface functionalization and bioconjugation strategies, this study aims to highlight their efficacy in targeted therapy, imaging, and theranostic applications. Furthermore, we discuss the current challenges, such as scalability, biocompatibility, and regulatory hurdles, while proposing future directions to enhance their clinical translation. This comprehensive review underscores the transformative potential of 177Lu-labeled magnetic nano-formulations in precision medicine and their role in shaping the future of therapeutic interventions.